JumpCloud: Most businesses aren’t truly ready for AI
As developers begin using Claude and Codex to help create Mac, iPhone, and iPad apps in Xcode, spare a moment to consider a recent JumpCloud
another news portal
As developers begin using Claude and Codex to help create Mac, iPhone, and iPad apps in Xcode, spare a moment to consider a recent JumpCloud
Can run many agents simultaneously, targets developer teams.
Thinking about self-hosting an ebook library? Here are the open source software you can consider.
The maker of ChatGPT hopes to triple its revenue in the coming year because it is planning to spend tens of billions of dollars. The
In 2024, public charging in California expanded at record levels The state has double the publicly accessible chargers versus 2022 Nearly 30% of U.S. EV
Owners report more than ten times the issues with Shell Recharge, EVgo, or Blink than with Tesla Rivian’s own charging network was second only to
Following three of the warmest years on record, as scientists reckon with climate tipping points and states and cities grapple with the escalating cost of
Chinese researchers claim to have developed a process to recover nearly all of the lithium from used electric vehicle batteries for recycling. The Independent (via
The Federal Aviation Administration abruptly halted flights into and out of El Paso International Airport on Tuesday night at 11:30 pm local time (1:30 am
The digital workplace has outgrown the simple project checklists you may have once associated with task management apps. The software has moved from passive repositories
If I told any average person that my Android phone’s notifications could now be sticky, shareable, and extra-smart about snoozing, they’d probably look at me
For families living with neurodegenerative disease, the hardest part is not always the diagnosis. It is the slow erosion that follows: memory fading, personality shifting
We stand at one of history’s most exhilarating crossroads. Artificial intelligence is rewriting the rules of work, business, and human potential at breathtaking speed. The
The Food and Drug Administration has refused to review Moderna’s application for an mRNA flu vaccine, the company revealed Tuesday. While the move came as